Propofol - Pacira

Drug Profile

Propofol - Pacira

Alternative Names: IDD Propofol; Propofol IDD-D

Latest Information Update: 11 Dec 2007

Price : $50

At a glance

  • Originator SkyePharma Inc
  • Developer Pacira Pharmaceuticals
  • Class General anaesthetics; Phenols; Small molecules
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anaesthesia

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 11 Dec 2007 Discontinued - Phase-II for Anaesthesia in USA (Injection)
  • 22 Jun 2007 SkyePharma Inc is now called Pacira Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top